Log In
| Medical Guidelines | Reason for Update |
|---|---|
| Ablative Techniques for the Myolysis of Uterine Fibroids | References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Bone Mineral Density Studies | Replaced “patient” with “individual” throughout policy. Policy Guidelines updated. References updated. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to Policy statement. |
| Bronchial Thermoplasty | Minor edits throughout policy. References updated. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Convection-Enhanced Delivery of Therapeutic Agents to the Brain | Specialty Matched Consultant Advisory Panel review 3/2025. Updated and added references. No change to policy statement. |
| Cord Blood as a Source of Stem Cells | Specialty Matched Consultant Advisory Panel review 3/2025. References added. |
| Electromagnetic Navigation Bronchoscopy | Description, Policy Guidelines, and References updated. Updated “patient” to “individual” where applicable throughout policy. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Endobronchial Valves | Description, Policy Guidelines, and References updated. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Heart-Lung Transplantation | Description and Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Hormone Pellet Implantation for Treatment of Menopause Related Symptoms | Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director Review 3/2025. References updated. No change to policy statement. |
| Infertility Diagnosis and Treatment – B0006 | Updated link in Policy Guidelines to reflect updated version of current guidance on the limits to the number of embryos to transfer. References updated. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Lung and Lobar Lung Transplantation | Description and Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Lung Volume Reduction Surgery | Description and Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Maternal and Fetal Diagnostics | References updated. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Monoclonal Antibody Imaging for Prostate Cancer | Specialty Matched Consultant Advisory Panel review 3/2025. References added. |
| Noninvasive Respiratory Assist Devices | Updated “patient” to “individual” where applicable throughout policy. References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
| Oncologic Applications of Photodynamic Therapy, Including Barrett’s Esophagus | Specialty Matched Consultant Advisory Panel review 3/2025. References added. |
| Oscillatory Devices for the Treatment of Respiratory Conditions | Minor updates to Policy Guidelines. References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No changes to policy statement. |
| Ovarian and Internal Iliac Vein Embolization, Ablation and Sclerotherapy | Description and Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director Review 3/2025. No change to policy statement. |
| Phrenic Nerve Stimulation for Central Sleep Apnea | Description and Regulatory Status updated. References added. Specialty Matched Consultant Advisory Panel 3/2025. Medical Director review 3/2024. No changes to policy statement. |
| Sleep Apnea: Diagnosis and Medical Management | Description updated. Updated “patient” to “individual” where applicable throughout policy. References added. Specialty Matched Consultant Advisory Panel Review 3/2025. Medical Director Review 3/2025. No change to policy statement. |
| Surgery for Obstructive Sleep Apnea and Upper Airway Resistance Syndrome | References added. Specialty Matched Consultant Advisory Panel review 3/2025. Medical Director review 3/2025. No change to policy statement. |
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.